Amgen reports new data from Phase 3 registrational MINT trial of Uplinza
Amgen (AMGN) announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of Uplinza in adults living with ...
Dave & Buster’s launches UFC Challenge game
Dave & Buster’s is taking its partnership with UFC to the next level with the launch of the UFC Challenge game. Available now at Dave & ...
DelveInsight Business Research, LLP: Psoriatic Arthritis Market Sees Major Shift with Growing Biosimilar Adoption | DelveInsight
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...